APPM Master Formulary 2024 (6th edition)
The APPM Formulary is the leading prescribing reference for professionals working in paediatric palliative care. Developed by the Association for Paediatric Palliative Medicine (APPM), it provides specialist guidance on medicines used to manage symptoms in babies, children and young people with life-limiting and life-threatening conditions.
The newly launched 7th Edition is available in both print and digital formats.
Key Highlights of the 7th Edition
- Updated opioid conversion tables, to reflect emerging evidence that oral morphine equivalence in children may differ from that reported in adults.
- Removal of direct IV/SC morphine conversions, with new recommendations to convert via oral morphine using updated paediatric equianalgesic ratios
- Clearer, more consistent formatting across monographs, with improved separation of therapeutic and administration information
- Substantially revised monographs: Buprenorphine, Clonidine, Haloperidol, Ketamine, Levomepromazine, Oxygen
- New monographs: Cyproheptadine, Esomeprazole, Naloxegol, Nefopam
New appendices include:
- Steroids in paediatric palliative care
- Prescribing in chronic kidney disease
- Anticonvulsant administration via alternative routes
- Mixing medicines for syringe driver administration